
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
This white paper provides actionable insights into FDA expectations, industry best practices, and free tools to mitigate the risk of FDA Observations






